2021 in Review and What ’ s Next
13
Positive Phase III Results
MJFF partner Amneal Pharmaceuticals in New Jersey announced positive Phase III results from their carbidopa / levodopa extended-release compound . The extended-release capsules worked better than immediate-release tablets at reducing “ off ” time in people with advanced Parkinson ’ s and motor fluctuations . They plan on submitting a New Drug Application to the FDA mid-2022 .
New App Makes DBS Adjustments More Accessible
Abbott , maker of Infinity deep brain stimulation ( DBS ) devices , now allows patients to receive stimulation adjustments remotely through an app . This technology can help if you live far from your doctor or have issues with travel . MJFF successfully advocated for insurance coverage of this service during the COVID-19 pandemic .
“ I ’ m quite encouraged about the momentum in drug development led by MJFF in partnership with the PD community .”
— Jeff Keefer , Vice Chairman , MJFF Board of Directors